Effects of saffron and barberry on components of metabolic syndrome

Phase 2

• Conditions: Metabolic disorder.; Other metabolic disorders

• Registration Number: IRCT2016112617756N11
• Lead Sponsor: Vice-chancellor for Research, Birjand University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

age between 30 and 60 years; individuals with metabolic syndrome defined by the Adult Treatment Panel III (ATP III); provision of informed consent; absence of any history of major cardiac, pulmonary, hepatic, gastroenterological, neurologic, psychiatric, or renal disease; non-pregnancy; Exclusion criterion: Unwillingness to continue participation

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Body Mass Index. Timepoint: Before intervention and three weeks after intervention. Method of measurement: a Seca 200 scale with attached stadiometer.;Hypertension. Timepoint: Before intervention and three weeks after intervention. Method of measurement: mercury sphygmomanometer.;Fasting blood sugar (FBS). Timepoint: Before intervention and three weeks after intervention. Method of measurement: ParsAzmun kit.;Triglyceride (TG). Timepoint: Before intervention and three weeks after intervention. Method of measurement: ParsAzmun Kit.;Total cholesterol (Chol). Timepoint: Before intervention and three weeks after intervention. Method of measurement: ParsAzmun Kit.;Low- and high-density lipoprotein (LDL and HDL). Timepoint: Before intervention and three weeks after intervention. Method of measurement: ParsAzmun Kit.